Clinical Trial

Preventing Alzheimer's With Cognitive Training

Study acronym: PACT
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2024 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Dementia is the most expensive medical condition in the US and increases in prevalence with age. More than 5 million Americans have Alzheimer's disease, the most common form of dementia. Mild cognitive impairment is a transitional stage between normal cognitive aging and Alzheimer's disease or another type of dementia, and is indicative of higher risk for dementia. In addition to the obvious health and quality-of-life ramifications of dementia, there are high direct (e.g., subsidizing residential care needs) and indirect (e.g., lost productivity of family caregivers) economic costs. Implementing interventions to prevent MCI and dementia among older adults is of critical importance to health and maintained quality-of-life for millions of Americans. Recent data analyses from the Advanced Cognitive Training in Vital Elderly study (ACTIVE) indicate that a specific cognitive intervention, speed of processing training (SPT), significantly delays the incidence of cognitive impairment across 10 years. The primary contribution of the proposed research will be the determination of whether this cognitive training technique successfully delays the onset of clinically defined MCI or dementia across three years.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2019-02-18; most recent amendment 2024-09-24.
Status change: Active, Not Recruiting → Recruiting 2021-04-09
Status change: Recruiting → Active, Not Recruiting 2021-01-05
Trial Details
NCT Number NCT03848312
Lead Sponsor University of South Florida
Collaborators: National Institute on Aging (NIA)
Conditions Age-related Cognitive Decline, Alzheimer's Disease and Related Dementias
Enrollment 7,600 participants
Start Date 2019-02-19
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-26